Laurion Capital Management LP Mei Pharma, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $1.08 Million - $1.67 Million	2,576,900 New	2,576,900 $1.56 Million
Q2 2019 Aug 13, 2019	SELL	$2.45 - $3.32 $293,975 - $398,366	-119,990 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$2.52 - $3.24 $221,286 - $284,510	87,812 Added 272.89%	119,990 $368,000
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $61,781 - $131,929	32,178 New	32,178 $85,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.